Dailiport 0.5 mg Prolonged-release hard capsules
- Licence status
- Withdrawn: 12/10/2021
- Active substances
- Tacrolimus
- Dosage Form
- Prolonged-release capsule, hard
- Licence number
- PA0711/294/001
- Licence holder
- Rowex Ltd
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- L04AD Calcineurin inhibitors, L04AD02 tacrolimus
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 17/01/2020